AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Careful Therapy Considerations Could Ease Resistance Problems.(Brief Article)

Vaccine Weekly

| June 06, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 JUN 6 - (NewsRx.com & NewsRx.net) --

by N.R. Saltmarsh, staff medical writer - When prescribing antibiotics for pneumococcal infections, clinicians are justifiably nervous about growing resistance problems.

But they may be leaning too far in the other direction if they always choose a new generation or class of antibiotics, say researchers who conducted an extensive review of Medline and other data.

G.W. Amsden and colleagues sought to clarify treatment considerations for Pneumococcus infections in light of growing drug resistance. Their findings were published in the Annals of Pharmacotherapy.

Reports of pneumococcal isolates that are resistant to one or more classes of antibiotics are becoming more frequent, said Amsden and team, resulting in significant shifts in treatment.

But are those treatment decisions being made without carefully weighing all the ramifications?

"Although clinicians have shifted to a new generation or class of antibiotics when faced with a resistance trend, data with resistant pneumococci show that this may not be necessary," said Amsden et al.

Related articles from newspapers, magazines, journals, and more
Corrosion resistance problems.(POWDER COATING CLINIC)
Magazine article from: Products Finishing Liberto, Nick November 1, 2006 700+ words
Q1. I stumbled across your forum while, Googling. We are manufacturing a line of insulated pipe guides and slides with a B-117 1,000 hr powder coat surface. Many mechanical specifications insist on hot-dip galvanizing for steam tunnels or outdoor applications. Is there any side by side comparison
NARMS data show resistance problems not mitigated, Angulo says.(National...
Newspaper article from: Food Chemical News Osvath, Rebecca October 2, 2000 700+ words
The latest figures from the Centers for Disease Control and Prevention show that pathogen resistance in humans to antimicrobial agents has not been mitigated, CDC's Fred Angulo told Food Chemical News last week. A collaborative project of the Centers for Disease Control and Prevention, FDA and
New topical antibiotic may thwart resistance problems.(Infectious Diseases)
Magazine article from: Family Practice News August 15, 2006 700+ words
Lisbon -- Five days of the novel topical antibiotic retapamulin is as effective in the treatment of uncomplicated skin infections as 10 days of an oral cephalosporin, Dr. Lawrence C. Parish reported at the 12th International Congress on Infectious Diseases. Patients prefer topical over systemic
New enthusiasm for diuretics may be tempered by resistance problems.
Newspaper article from: Heart Disease Weekly March 9, 2003 700+ words
2003 MAR 9 - (NewsRx.com & NewsRx.net) -- New research appears to contradict a widely publicized study that concluded that cheap, old-fashioned diuretics should be the first drug given to people with high blood pressure. The conclusion that "water pills" are as good as, if not better than,
Biotech announces appointment of COO.
Newspaper article from: Vaccine Weekly February 25, 2004 700+ words
...vaccine. Additionally, the company has several vaccines in preclinical development. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
DNA-based vaccines being developed to battle bioterrorism.
Newspaper article from: Vaccine Weekly February 25, 2004 700+ words
...Development, DNA Vaccine, Biowarfare, Gene Therapy, Immunology, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Poxvirus used for delivery of stimulatory molecules to melanoma tumors.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Delivery, Skin Cancer, Dermatology, Immunotherapy, Vaccine Development, and Oncology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Broadly cross-reactive HIV-neutralizing antibody Fab identified.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Therapy, Vaccine Development, Monoclonal Antibodies, Diagnostics, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Arginine-glysine-aspartate motif enhances immunogenicity of antigens.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Delivery, Vaccine Development, Vaccine Efficacy, Immunology, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Cancer vaccine using low affinity epitopes proves successful in mice.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...This article may be viewed at https://www.the-jci.org/press/19418.pdf. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
For more facts and information, see all results

Source: HighBeam Research, Careful Therapy Considerations Could Ease Resistance Problems.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA